Quantcast
Last updated on April 19, 2014 at 13:20 EDT

DuPont Grows Second Quarter Earnings 8 Percent to $1.48 Ex-items

July 24, 2012

WILMINGTON, Del., July 24, 2012 /PRNewswire/ –

Highlights:

  • Second-quarter 2012 earnings were $1.48 per share versus $1.37 per share in the prior year, excluding significant items from both periods. Reported second-quarter earnings were $1.25 per share versus $1.29 per share in the prior year.
  • Sales increased 7 percent to $11.0 billion reflecting 6 percent higher local prices and a 5 percent increase from portfolio changes, partially offset by a 3 percent reduction from currency and 1 percent lower sales volume. Sales in developing markets grew 11 percent.
  • Segment pre-tax operating income, excluding pharmaceuticals and significant items, increased 13 percent, principally attributable to higher earnings from Agriculture and Performance Materials and a prior-year acquisition benefiting Nutrition & Health and Industrial Biosciences.
  • For the first half of 2012, Agriculture delivered 15 percent sales growth and 16 percent higher pre-tax operating income excluding significant items, reflecting strong northern-hemisphere business performance across both seed and crop protection product lines.
  • The company is on track versus its full-year 2012 productivity targets for fixed costs and working capital. Year-to-date fixed cost productivity totals $190 million.
  • DuPont expects full-year earnings to be toward the lower end of its existing outlook range of $4.20 to $4.40 per share, excluding significant items, due to uncertainties associated with macros and currency as well as a higher tax rate related to earnings mix. Prior year earnings were $3.93 per share on a comparable basis.

“Our agriculture, food and bioscience businesses are performing exceptionally well globally, and our advanced materials businesses are achieving solid results despite slower growth in some key markets and continued weakness in Europe,” said DuPont Chair and CEO Ellen Kullman. “Our global teams continue to execute well in a dynamic environment, while investing for growth driven by science-powered innovation and collaboration.”

Global Consolidated Sales and Net Income

Second-quarter 2012 consolidated net sales of $11.0 billion were 7 percent higher than the prior year reflecting 6 percent higher local prices and a 5 percent net increase from portfolio changes, partly offset by a 3 percent negative currency impact and 1 percent lower volume.

The table below shows regional sales and variances versus the second quarter 2011.

                                   Three Months Ended Percentage Change Due to:
                                    June 30, 2012
                                    -------------
    (Dollars in billions)                             $  % Change               Local Price   Currency Effect     Volume     Portfolio/
                                                                                                                                Other
                                                                                                                                -----
    U.S. & Canada                                  $5.0               12                    8                  -          2             2
    EMEA*                                           2.5               (2)                   5                 (7)        (8)            8
    Asia Pacific                                    2.4                5                    1                 (1)        (1)            6
    Latin America                                   1.1               14                    9                 (5)         4             6

    Total Consolidated Sales                      $11.0                7                    6                 (3)        (1)            5

    * Europe, Middle East & Africa

Second-quarter 2012 net income attributable to DuPont was $1,179 million versus $1,218 million in 2011. Excluding significant items, net income attributable to DuPont of $1,394 million increased $95 million, or 7 percent, from $1,299 million in the second quarter 2011.

Earnings Per Share

The table below shows year-over-year earnings per share (EPS) variances for the second quarter.

                                                 EPS ANALYSIS
                                                 ------------

                                                                2Q
                                                               ---

    EPS 2011                                                   $1.29
    Less: Significant items (schedule B)                      ( .08)
                                                               -----
    EPS 2011 - Excluding significant items                     $1.37
    Local prices
                                                                 .49
    Variable cost*                                              (.03)
    Volume                                                      (.06)
    Fixed cost*                                                 (.15)
    Currency                                                    (.06)
    Portfolio changes                                            .06
    Exchange losses                                             (.04)
    Income tax                                                  (.02)
    Pharmaceuticals income                                      (.05)
    Other                                                       (.03)
                                                                ----

    EPS 2012 - Excluding significant items                     $1.48
       Significant items - (schedule B)                         (.23)
                                                                ----
    EPS 2012                                                   $1.25

    *                   Excluding volume and currency impacts

Business Segment Performance

The table below shows second quarter 2012 segment sales and related variances versus the prior year.

    SEGMENT SALES*                       Three Months Ended Percentage Change
    (Dollars in billions)                 June 30, 2012 Due to:
                                          ------------- -------
                                                         $ % Change            USD      Volume      Portfolio
                                                                              Price                 and Other
                                                                                                    ---------
    Agriculture                                        $3.4             13           7           6      -
    Electronics & Communications                        0.8            (11)         (5)         (6)     -
    Industrial Biosciences                              0.3            144           -          10            134
    Nutrition & Health                                  0.9             82           -           5             77
    Performance Chemicals                               2.0             (1)          9         (10)             -
    Performance Coatings                                1.1             (1)          1          (2)             -
    Performance Materials                               1.7             (3)         (1)          1             (3)
    Safety & Protection                                 1.0             (4)          1          (5)             -

    *    Segment sales include transfers

Segment pre-tax operating income (PTOI) for second quarter 2012 was $1,898 million compared to second quarter 2011 PTOI of $1,943 million. Excluding significant items, PTOI was $2,178 million, up 9 percent from $1,993 million in the prior year, as shown in the table below.

    SEGMENT PTOI excluding Significant Items*                                                Change versus 2011
                                                                                             ------------------
    (Dollars in millions)                                      2Q 2012                    2Q 2011            $   %
                                                               -------                    -------          ---  ---

    Agriculture                                                          $926                       $826  $100       12%
    Electronics & Communications                                           75                        103   (28)     -27%
    Industrial Biosciences                                                 44                         10    34      340%
    Nutrition & Health                                                    112                         38    74      195%
    Performance Chemicals                                                 538                        503    35        7%
    Performance Coatings                                                   92                         73    19       26%
    Performance Materials                                                 317                        254    63       25%
    Safety & Protection                                                   127                        143   (16)     -11%
    Other                                                                 (69)                       (37)  (32)      nm
                                                                          ---                        ---   ---
                                                                       $2,162                     $1,913  $249       13%
    Pharmaceuticals                                                        16                         80   (64)     -80%
                                                                          ---                        ---   ---
    Total Segment PTOI                                                 $2,178                     $1,993  $185        9%

    * See schedules B and C for listing of significant items and their impact by segment.

The following is a summary of business results for each of the company’s reportable segments, comparing second quarter 2012 with second quarter 2011, for sales and PTOI, excluding significant items. References to selling price are on a U.S. dollar basis, including the impact of currency.

Agriculture – Sales of $3.4 billion were up $0.4 billion, or 13 percent, with 7 percent price and 6 percent volume gains. Pioneer seed maintained its momentum delivering 12 percent sales growth on agriculture macros and strong business performance in North America corn and soybeans. Crop Protection sales growth of 15 percent was underpinned by strong demand across all product lines. PTOI of $926 million improved 12 percent on strong sales performance partially offset by input cost increases in seeds, unfavorable currency impact and higher investments in Right Product Right Acre commercial and R&D activities.

First half sales of $7.5 billion were up $1.0 billion, or 15 percent, with 8 percent volume and 7 percent price gains. Pioneer seed sales growth of 16 percent reflects strong northern hemisphere performance with global price and volume gains on new product penetration. Crop Protection sales growth of 11 percent reflects continued strong demand in all product lines with standout performance in insect control products. PTOI for the first half of $2.2 billion improved 16 percent on higher volume and price partially offset by input cost increases in seeds, unfavorable currency impact and higher spending for growth investments.

Electronics & Communications – Sales of $795 million were down 11 percent on 6 percent lower volume and 5 percent lower selling prices, primarily pass-through of lower metals prices. Sales reflect continued soft demand for photovoltaic materials, though up sequentially from first quarter. Volume decline in photovoltaics was partially offset by increased demand for smart phones and tablets. PTOI of $75 million declined $28 million from lower volume and plant utilization. Additionally, PTOI in the prior year included a $20 million reduction due to extreme volatility in metals prices.

Industrial Biosciences - Sales of $300 million were up $177 million, primarily due to two months acquisition benefit from the Danisco enzyme business. Biomaterial sales into apparel and carpeting accounted for a 10 percent volume increase. PTOI of $44 million was up $34 million benefiting from the acquisition and realization of cost synergies. PTOI includes $5 million of amortization expense associated with the fair value step-up of acquired intangible assets.

Nutrition & Health - Sales of $885 million were up $399 million, or 82 percent, primarily reflecting two months acquisition benefit from the Danisco specialty food ingredients business. Higher volume reflects continued strong demand in Solae specialty soy products. PTOI of $112 million was up $74 million benefiting from the acquisition, realization of cost synergies and favorable product mix in Solae. PTOI includes $20 million of amortization expense associated with the fair value step-up of acquired intangible assets.

Performance Chemicals – Sales of $2.0 billion were down 1 percent, with 10 percent lower volume partially offset by 9 percent higher selling prices. Higher selling prices more than offset higher ore costs. Lower volume reflects continued softness in titanium dioxide, particularly in Asia Pacific and Europe, and weakening demand in fluoropolymers. PTOI of $538 million increased $35 million on higher selling prices and continued productivity actions.

Performance Coatings – Sales of $1.1 billion were down 1 percent, with 2 percent lower volume partially offset by 1 percent higher selling prices. OEM volume growth in North America and Asia Pacific was more than offset by lower refinish and powder coatings volume, particularly in European markets. Higher local selling prices across all regions and market segments were partially offset by the impact of unfavorable currency. PTOI of $92 million increased $19 million on higher selling prices, mix enrichment and continued productivity actions, partially offset by unfavorable currency.

Performance Materials – Sales of $1.7 billion were down 3 percent, primarily reflecting a 3 percent reduction from a portfolio change and 1 percent lower selling prices, partially offset by 1 percent higher volume. The lower selling prices were primarily affected by unfavorable currency. Volume growth in packaging markets and continued strong demand in the automotive market, particularly in North America, were partially offset by softness in the industrial and electronic markets. PTOI of $317 million increased $63 million due to lower feedstock costs and higher volume, partially offset by unfavorable currency.

Safety & Protection - Sales of $986 million were down 4 percent, with 5 percent lower volume partially offset by 1 percent higher selling prices. Volume declined due to lower public sector demand and continued softness in industrial markets. Higher local selling prices from value-based pricing were partially offset by the impact of unfavorable currency. PTOI of $127 million decreased $16 million on weaker mix, unfavorable currency and higher spending for growth initiatives, partially offset by value-based pricing actions.

Additional information is available on the DuPont Investor Center website at www.investors.dupont.com.

Outlook

DuPont expects full-year earnings to be toward the lower end of its existing outlook range of $4.20 to $4.40 per share, excluding significant items, due to uncertainties associated with macros and currency as well as a higher tax rate related to earnings mix. Prior year earnings were $3.93 per share on a comparable basis.

Use of Non-GAAP Measures

Management believes that certain non-GAAP measurements are meaningful to investors because they provide insight with respect to ongoing operating results of the company. Such measurements are not recognized in accordance with generally accepted accounting principles (GAAP) and should not be viewed as an alternative to GAAP measures of performance. Reconciliations of non-GAAP measures to GAAP are provided in schedules C and D.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

Forward-Looking Statements: This news release contains forward-looking statements which may be identified by their use of words like “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “estimates” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the company’s growth strategy, product development, regulatory approval, market position, anticipated benefits of acquisitions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward-looking statements. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company’s control. Some of the important factors that could cause the company’s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, weather events and natural disasters; inability to protect and enforce the company’s intellectual property rights; and integration of acquired businesses and completion of divestitures of underperforming or non-strategic assets or businesses. The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.

                                                                                            E. I. du Pont de Nemours and Company
                                                                                               Consolidated Income Statements
                                                                                       (Dollars in millions, except per share amounts)
    SCHEDULE A
                                                                                                    Three Months Ended                 Six Months Ended
                                                                                                         June 30,                          June 30,
                                                                                                         --------                          --------
                                                                                                                           2012                             2011        2012        2011
                                                                                                                           ----                             ----        ----        ----
    Net sales                                                                                                           $11,006                          $10,264     $22,236     $20,298
    Other income, net(a)                                                                                                    277                              229         303         254
                                                                                                                            ---                              ---         ---         ---
    Total                                                                                                                11,283                           10,493      22,539      20,552

    Cost of goods sold and other operating charges (a)                                                                    7,815                            7,191      15,342      14,022
    Selling, general and administrative expenses                                                                          1,186                            1,136       2,355       2,163
    Research and development expense                                                                                        528                              462       1,033         861
    Interest expense                                                                                                        117                              115         231         215
                                                                                                                            ---                              ---         ---         ---
    Total                                                                                                                 9,646                            8,904      18,961      17,261

    Income before income taxes                                                                                            1,637                            1,589       3,578       3,291
    Provision for (benefit from) income taxes                                                                               449                              360         890         618
                                                                                                                            ---                              ---         ---         ---

    Net income                                                                                                            1,188                            1,229       2,688       2,673

    Less:  Net income attributable to noncontrolling interests                                                                9                               11          21          24
                                                                                                                            ---                              ---         ---         ---

    Net income attributable to DuPont                                                                                    $1,179                           $1,218      $2,667      $2,649
                                                                                                                         ======                           ======      ======      ======

    Basic earnings per share of common stock                                                                              $1.26                            $1.31       $2.85       $2.85
                                                                                                                          =====                            =====       =====       =====

    Diluted earnings per share of common stock                                                                            $1.25                            $1.29       $2.82       $2.80
                                                                                                                          =====                            =====       =====       =====

    Dividends per share of common stock                                                                                   $0.43                            $0.41       $0.84       $0.82
                                                                                                                          =====                            =====       =====       =====

    Average number of shares outstanding used in earnings per share (EPS) calculation:
      Basic                                                                                                         934,057,000                      930,798,000 933,982,000 927,860,000
      Diluted                                                                                                       942,832,000                      943,987,000 943,533,000 942,461,000

    (a) See Schedule B for detail of significant items.


                                           E. I. du Pont de Nemours and Company
                                          Condensed Consolidated Balance Sheets
                                     (Dollars in millions, except per share amounts)
    SCHEDULE A (continued)
                                                         June 30,                    December 31,
                                                                          2012                       2011
                                                                          ----                       ----
    Assets
    Current assets
    Cash and cash equivalents                                           $3,506                     $3,586
    Marketable securities                                                   50                        433
    Accounts and notes receivable,
     net                                                                 9,476                      6,022
    Inventories                                                          6,011                      7,195
    Prepaid expenses                                                       151                        151
    Deferred income taxes                                                  932                        671
                                                                           ---                        ---
    Total current assets                                                20,126                     18,058
    Property, plant and equipment,
     net of accumulated depreciation                                    13,342                     13,412
       (June 30, 2012 -$19,962;
        December 31, 2011 -$19,349)
    Goodwill                                                             5,348                      5,413
    Other intangible assets                                              5,228                      5,413
    Investment in affiliates                                             1,087                      1,117
    Deferred income taxes                                                3,822                      4,067
    Other assets                                                         1,078                      1,012
                                                                         -----                      -----
    Total                                                              $50,031                    $48,492
                                                                       =======                    =======

    Liabilities and Equity
    Current liabilities
    Accounts payable                                                    $3,695                     $4,816
    Short-term borrowings and
     capital lease obligations                                           3,696                        817
    Income taxes                                                           930                        255
    Other accrued liabilities                                            4,117                      5,297
                                                                         -----                      -----
    Total current liabilities                                           12,438                     11,185
    Long-term borrowings and
     capital lease obligations                                          11,254                     11,736
    Other liabilities                                                   14,643                     15,508
    Deferred income taxes                                                1,051                      1,001
                                                                         -----                      -----
    Total liabilities                                                   39,386                     39,430
                                                                        ------                     ------

    Commitments and contingent
     liabilities

    Stockholders' equity
    Preferred stock                                                        237                        237
    Common stock, $0.30 par value;
     1,800,000,000 shares
     authorized;                                                           305                        304
       issued at June 30, 2012 -
        1,017,365,000; December 31,
        2011 -1,013,164,000
    Additional paid-in capital                                          10,494                     10,107
    Reinvested earnings                                                 14,975                     13,422
    Accumulated other comprehensive
     loss                                                               (8,743)                    (8,750)
    Common stock held in treasury,
     at cost (87,041,000 shares                                         (6,727)                    (6,727)
       at June 30, 2012 and December
        31, 2011)

    Total DuPont stockholders'
     equity                                                             10,541                      8,593
                                                                        ------                      -----
    Noncontrolling interests                                               104                        469
                                                                           ---                        ---
    Total equity                                                        10,645                      9,062
                                                                        ------                      -----
    Total                                                              $50,031                    $48,492
                                                                       =======                    =======


              E. I. du Pont de Nemours and Company
         Condensed Consolidated Statement of Cash Flows
                      (Dollars in millions)
    SCHEDULE A (continued)
                                          Six Months Ended
                                              June 30,
                                              --------
                                             2012               2011
                                             ----               ----

    Cash provided by (used for)
     operating activities                 $(1,117)             $(644)
                                          -------              -----

    Investing activities
    Purchases of property, plant and
     equipment                               (696)              (741)
    Investments in affiliates                 (14)               (27)
    Payments for businesses (net of
     cash acquired)                             -             (6,264)
    Proceeds from sales of assets -
     net of cash sold                         166                 59
    Net (increase) decrease in short-
     term financial instruments               388              2,404
    Forward exchange contract
     settlements                               80               (454)
    Other investing activities - net           (7)               (13)
                                              ---                ---
    Cash provided by (used for)
     investing activities                     (83)            (5,036)

    Financing activities
    Dividends paid to stockholders           (788)              (767)
    Net increase (decrease) in
     borrowings                             2,406              3,823
    Repurchase of common stock               (400)              (272)
    Proceeds from exercise of stock
     options                                  406                768
    Payments for non-controlling
     interest                                (447)                 -
    Other financing activities - net           27                (22)
                                              ---                ---
    Cash provided by (used for)
     financing activities                   1,204              3,530

    Effect of exchange rate changes on
     cash                                     (84)               155
                                              ---                ---

    Increase (decrease) in cash and
     cash equivalents                         (80)            (1,995)

    Cash and cash equivalents at
     beginning of period                    3,586              4,263
                                            -----              -----

    Cash and cash equivalents at end
     of period                             $3,506             $2,268
                                           ======             ======

                                                                                                               E. I. du Pont de Nemours and Company
                                                                                                                  Schedule of Significant Items
                                                                                                         (Dollars in millions, except per share amounts)
    SCHEDULE B
    SIGNIFICANT ITEMS
                                                                                                              Pre-tax                                              After-tax                       ($ Per Share)
                                                                                                              -------                                              ---------                        ------------
                                                                                                           2012                                          2011                2012                                2011           2012                      2011
                                                                                                           ----                                          ----                ----                                ----           ----                      ----
    1st Quarter
    -----------
    Customer claims charge (a)                                                                $(50)              $            -                                 $(32)              $            -                      $(0.04)        $               -

    1st Quarter - Total                                                                       $(50)              $            -                                 $(32)              $            -                      $(0.04)        $               -
                                                                                              ====               ==============                                 ====               ==============                      ======         =================

    2nd Quarter
    -----------
    Customer claims charge (a)                                                               $(265)              $            -                                $(169)              $            -                      $(0.18)        $               -
    Litigation settlement (b)                                                                              (137)                                            -                (123)                                  -          (0.13)                        -
    Gain on the sale of equity
                                          method investment (c)                                             122                                             -                  77                                   -           0.08                         -
    Transition costs related to the
                                          acquisition of Danisco (d)                                          -                                          (103)                  -                                 (81)             -                     (0.08)
    2nd Quarter - Total                                                                      $(280)                       $(103)                               $(215)                        $(81)                     $(0.23)                   $(0.08)
                                                                                             =====                        =====                                =====                         ====                      ======                    ======

    Year-to-date - Total (e)                                                                 $(330)                       $(103)                               $(247)                        $(81)                     $(0.26)                   $(0.09)
                                                                                             =====                        =====                                =====                         ====                      ======                    ======

    (a)                                    First quarter and second quarter 2012 included charges of $50 and $265, respectively, recorded in Cost of
                                           goods sold and other operating charges associated with the company's process to fairly resolve claims
                                           related to the use of Imprelis(R) herbicide, bringing the total charges to $490 at June 30, 2012.  The
                                           company will continue to evaluate reported claim damage as additional information becomes available. It is
                                           reasonably possible that additional charges could result from this evaluation. While there is a high degree
                                           of uncertainty, total charges could range as high as $575. The company has submitted, and will continue to
                                           submit, requests for payment to its insurance carriers for costs associated with this matter in excess of
                                           $100.  This matter relates to the Agriculture segment.

    (b)                                    Second quarter 2012 included a charge of $137 recorded in Cost of goods sold and other operating charges
                                           primarily related to the company's settlement of litigation with Invista.  This matter relates to Other.

    (c)                                    Second quarter 2012 included a pre-tax gain of $122 recorded in Other income, net associated with the sale
                                           of an equity method investment in the Electronics & Communications segment.

    (d)                                    Second quarter 2011 included charges related to the Danisco acquisition of $(103) recorded in Cost of goods
                                           sold and other operating charges.  These charges included $(60) of transaction costs and a $(43) charge
                                           related to the fair value step-up of inventories that were acquired from Danisco and sold in the second
                                           quarter 2011. Pre-tax charges by segment were: Industrial Biosciences - $(17), Nutrition & Health -
                                           $(33), and Corporate expenses - $(53).

    (e)                                    Earnings per share for the year may not equal the sum of quarterly earnings per share due to changes in
                                           average share calculations.

    See Schedule C for detail by segment.


                                                                                                       E. I. du Pont de Nemours and Company
                                                                                                         Consolidated Segment Information
                                                                                                               (Dollars in millions)
    SCHEDULE C
                                                              Three Months Ended                                      Six Months Ended
                                                                   June 30,                                               June 30,
                                                                   --------                                               --------
    SEGMENT SALES (1)                                                                                           2012                                                  2011                                  2012                                  2011
    ----------------                                                                                            ----                                                  ----                                  ----                                  ----
    Agriculture                                                                                               $3,388                                                $2,997                                $7,468                                $6,501
    Electronics & Communications                                                                                 795                                                   891                                 1,472                                 1,702
    Industrial Biosciences                                                                                       300                                                   123                                   588                                   123
    Nutrition & Health                                                                                           885                                                   486                                 1,693                                   810
    Performance Chemicals                                                                                      1,968                                                 1,995                                 3,868                                 3,792
    Performance Coatings                                                                                       1,089                                                 1,105                                 2,139                                 2,098
    Performance Materials                                                                                      1,699                                                 1,745                                 3,299                                 3,452
    Safety & Protection                                                                                          986                                                 1,025                                 1,927                                 1,990
    Other                                                                                                          1                                                     1                                     2                                    37
    Total Segment sales                                                                                       11,111                                                10,368                                22,456                                20,505

    Elimination of transfers                                                                                    (105)                                                 (104)                                 (220)                                 (207)
    Consolidated net sales                                                                                   $11,006                                               $10,264                               $22,236                               $20,298
                                                                                                             =======                                               =======                               =======                               =======

    (1)   Sales for the reporting segments include transfers.

                                                                                 E. I. du Pont de Nemours and Company
                                                                                   Consolidated Segment Information
                                                                                        (Dollars in millions)
    SCHEDULE C (continued)
                                                                                   Three Months Ended                 Six Months Ended
                                                                                        June 30,                          June 30,
                                                                                        --------                          --------
    PRE-TAX OPERATING INCOME/(LOSS) (PTOI)                                                                  2012                         2011    2012      2011
    --------------------------------------                                                                  ----                         ----    ----      ----
    Agriculture                                                                                             $661                         $826  $1,925    $1,937
    Electronics & Communications                                                                             197                          103     230       214
    Industrial Biosciences                                                                                    44                           (7)     85        (7)
    Nutrition & Health                                                                                       112                            5     195        30
    Performance Chemicals                                                                                    538                          503   1,050       897
    Performance Coatings                                                                                      92                           73     179       138
    Performance Materials                                                                                    317                          254     557       542
    Safety & Protection                                                                                      127                          143     227       288
    Pharmaceuticals                                                                                           16                           80      43       130
    Other                                                                                                   (206)                         (37)   (266)     (101)
                                                                                                            ----                          ---    ----      ----
    Total Segment PTOI                                                                                     1,898                        1,943   4,225     4,068

    Net exchange gains (losses) (1)                                                                           28                            4     (52)     (139)
    Corporate expenses & net interest                                                                       (289)                        (358)   (595)     (638)
                                                                                                            ----                         ----    ----      ----
    Income before income taxes                                                                            $1,637                       $1,589  $3,578    $3,291
                                                                                                          ======                       ======  ======    ======

                                                                                   Three Months Ended                 Six Months Ended
                                                                                        June 30,                          June 30,
                                                                                        --------                          --------
    SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX) (2)                                                              2012                         2011    2012      2011
    -----------------------------------------                                                               ----                         ----    ----      ----
    Agriculture                                                                                            $(265)         $                 -   $(315) $      -
    Electronics & Communications                                                                             122                            -     122         -
    Industrial Biosciences                                                                                     -                          (17)      -       (17)
    Nutrition & Health                                                                                         -                          (33)      -       (33)
    Performance Chemicals                                                                                      -                            -       -         -
    Performance Coatings                                                                                       -                            -       -         -
    Performance Materials                                                                                      -                            -       -         -
    Safety & Protection                                                                                        -                            -       -         -
    Pharmaceuticals                                                                                            -                            -       -         -
    Other                                                                                                   (137)                           -    (137)        -
    Total significant items by segment                                                                     $(280)                        $(50)  $(330)     $(50)
                                                                                                           =====                         ====   =====      ====

                                                                                   Three Months Ended                 Six Months Ended
                                                                                        June 30,                          June 30,
                                                                                        --------                          --------
    PTOI EXCLUDING SIGNIFICANT ITEMS                                                                        2012                         2011    2012      2011
    --------------------------------                                                                        ----                         ----    ----      ----
    Agriculture                                                                                             $926                         $826  $2,240    $1,937
    Electronics & Communications                                                                              75                          103     108       214
    Industrial Biosciences                                                                                    44                           10      85        10
    Nutrition & Health                                                                                       112                           38     195        63
    Performance Chemicals                                                                                    538                          503   1,050       897
    Performance Coatings                                                                                      92                           73     179       138
    Performance Materials                                                                                    317                          254     557       542
    Safety & Protection                                                                                      127                          143     227       288
    Pharmaceuticals                                                                                           16                           80      43       130
    Other                                                                                                    (69)                         (37)   (129)     (101)
    Total Segment PTOI excluding significant items                                                        $2,178                       $1,993  $4,555    $4,118
                                                                                                          ======                       ======  ======    ======

    (1)  See Schedule D for additional information on exchange gains and losses.
    (2)  See Schedule B for detail of significant items.

                                                                                                                                         E. I. du Pont de Nemours and Company
                                                                                                                                          Reconciliation of Non-GAAP Measures
                                                                                                                                    (Dollars in millions, except per share amounts)
    SCHEDULE D

    Summary of Earnings Comparisons

                                                                         Three Months Ended                                           Six Months Ended
                                                                              June 30,                                                    June 30,
                                                                         --------                                                  --------
                                                                                                                             2012                                                         2011        %                       2012               2011       %
                                                                                                                                                                                                   Change                                                Change
                                                                                                                                                                                                   ------                                                ------

    Segment PTOI                                                                                                           $1,898                                                       $1,943              -2%             $4,225             $4,068             4%
    Significant items (benefit) charge included in PTOI (per Schedule C)                                                      280                                                           50                                 330                 50
                                                                                                                              ---                                                          ---                                 ---                ---
    Segment PTOI excluding significant items                                                                               $2,178                                                       $1,993               9%             $4,555             $4,118            11%
                                                                                                                           ======                                                       ======                              ======             ======

    Net income attributable to DuPont                                                                                      $1,179                                                       $1,218              -3%             $2,667             $2,649             1%
    Significant items (benefit) charge included in net income
    attributable to DuPont (per Schedule B)                                                                                   215                                                           81                                 247                 81
    Net income attributable to DuPont
    excluding significant items                                                           $1,394                                            $1,299                                              7%              $2,914             $2,730             7%
                                                                                          ======                                            ======                                                              ======             ======

    EPS                                                                                                                     $1.25                                                        $1.29              -3%              $2.82              $2.80             1%
    Significant items (benefit) charge included in EPS (per Schedule B)                                                      0.23                                                         0.08                                0.26               0.09
                                                                                                                             ----                                                         ----                                ----               ----
    EPS excluding significant items                                                                                         $1.48                                                        $1.37               8%              $3.08              $2.89             7%
                                                                                                                            =====                                                        =====                               =====              =====

    Average number of diluted shares outstanding                                                                      942,832,000                                                  943,987,000            -0.1%        943,533,000        942,461,000           0.1%

    Reconciliation of Earnings Per Share (EPS) Outlook
                                                                                                 Year Ended December 31,
                                                                                                 -----------------------
                                                                                                      2012 Outlook                                                  2011 Actual
                                                                                                      ------------                                                  -----------
    Earning per share - excluding significant items                                                                 $4.20 - $4.40                                                        $3.93
    Sale of an equity method investment                                                                                      0.08                                                            -
    Danisco acquisition related costs                                                                                           -                                                        (0.22)
    Customer claims charges                                                                                                 (0.21)                                                       (0.12)
    Charges related to a licensing agreement                                                                                    -                                                        (0.03)
    Sale of a business                                                                                                          -                                                         0.13
    Restructuring charge/adjustments                                                                                            -                                                        (0.01)
    Litigation Settlement                                                                                                   (0.13)                                                           -
    Reported EPS                                                                                                   $3.94 to $4.14                                                        $3.68
                                                                                                                   ==============                                                        =====
                                                                                                 E. I. du Pont de Nemours and Company
                                                                                                 Reconciliation of Non-GAAP Measures
                                                                                           (Dollars in millions, except per share amounts)

    SCHEDULE D (continued)

    Reconciliations of Adjusted EBIT / EBITDA to Consolidated Income Statements

                                                                                                                                                 Three Months Ended               Six Months Ended
                                                                                                                                                    June 30,                     June 30,
                                                                                                                                                    --------                     --------
                                                                                                                                                       2012            2011                     2012     2011
                                                                                                                                                       ----            ----                     ----     ----

    Income before income taxes                                                                                                                       $1,637          $1,589                   $3,578   $3,291
    Less: Net income attributable to noncontrolling interests                                                                                             9              11                       21       24
    Add:  Interest expense                                                                                                                              117             115                      231      215
                                                                                                                                                        ---             ---                      ---      ---
    Adjusted EBIT                                                                                                                                     1,745           1,693                    3,788    3,482
    Add: Depreciation and amortization                                                                                                                  445             383                      900      744
                                                                                                                                                        ---             ---                      ---      ---
    Adjusted EBITDA                                                                                                                                  $2,190          $2,076                   $4,688   $4,226
                                                                                                                                                     ======          ======                   ======   ======

    Calculation of Free Cash Flow

                                                                                                                                          Six Months Ended
                                                                                                                                               June 30,
                                                                                                                                               --------

                                                                                                                                                       2012            2011
                                                                                                                                                       ----            ----
    Cash provided by (used for) operating activities                                                                                                $(1,117)          $(644)
    Less: Purchases of property, plant and equipment                                                                                                    696             741
    Free cash flow                                                                                                                                  $(1,813)        $(1,385)
                                                                                                                                                    =======         =======

    Reconciliations of Fixed Costs as a Percent of Sales

                                                                                                                                               Three Months Ended            Six Months Ended
                                                                                                                                                    June 30,                     June 30,
                                                                                                                                                    --------                     --------
                                                                                                                                                       2012            2011                     2012     2011
                                                                                                                                                       ----            ----                     ----     ----

    Total charges and expenses - consolidated income statements                                                                                      $9,646          $8,904                  $18,961  $17,261
    Remove:
       Interest expense                                                                                                                                (117)           (115)                    (231)    (215)
       Variable costs (1)                                                                                                                            (5,072)         (4,936)                 (10,209)  (9,658)
       Significant items - benefit (charge) (2)                                                                                                        (402)           (103)                    (452)    (103)
           Fixed costs                                                                                                                               $4,055          $3,750                   $8,069   $7,285
                                                                                                                                                     ======          ======                   ======   ======

    Consolidated net sales                                                                                                                          $11,006         $10,264                  $22,236  $20,298

    Fixed costs as a percent of consolidated net sales                                                                                                 36.8%           36.5%                    36.3%    35.9%

    (1)  Includes variable manufacturing costs, freight, commissions and other selling expenses which vary with the volume of sales.
    (2)  See Schedule B for detail of significant items.
                                                                                                                           E. I. du Pont de Nemours and Company
                                                                                                                           Reconciliation of Non-GAAP Measures
                                                                                                                     (Dollars in millions, except per share amounts)

    SCHEDULE D (continued)

    Exchange Gains/(Losses)
    The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign
     currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes. The net pre-tax exchange gains and losses are recorded in Other income, net and the related tax impact is recorded in Provision for (benefit from) income taxes on the Consolidated
     Income Statements.

                                                                                                                                                       Three Months Ended                           Six Months Ended
                                                                                                                                                            June 30,                                    June 30,
                                                                                                                                                            --------                                    --------
                                                                                                                                                                            2012                                     2011                                          2012                         2011
                                                                                                                                                                            ----                                     ----                                          ----                         ----
    Subsidiary/Affiliate Monetary Position Gain (Loss)
    --------------------------------------------------
    Pre-tax exchange gains (losses) (includes equity affiliates)                                                                                                           $(210)                                     $55                                         $(162)                        $285
    Local tax benefits (expenses)                                                                                                                                             24                                      (10)                                           16                           (5)
                                                                                                                                                                             ---                                      ---                                           ---                          ---
    Net after-tax impact from subsidiary exchange gains (losses)                                                                                                           $(186)                                     $45                                         $(146)                        $280
                                                                                                                                                                           =====                                      ===                                         =====                         ====

    Hedging Program Gain (Loss)
    --------------------------
    Pre-tax exchange gains (losses)                                                                                                                                         $238                                     $(51)                                         $110                        $(424)
    Tax benefits (expenses)                                                                                                                                                  (83)                                      17                                           (39)                         147
                                                                                                                                                                             ---                                      ---                                           ---                          ---
    Net after-tax impact from hedging program exchange gains (losses)                                                                                                       $155                                     $(34)                                          $71                        $(277)
                                                                                                                                                                            ====                                     ====                                           ===                        =====

    Total Exchange Gain (Loss)
    -------------------------
    Pre-tax exchange gains (losses)                                                                                                                                          $28                                       $4                                          $(52)                       $(139)
    Tax benefits (expenses)                                                                                                                                                  (59)                                       7                                           (23)                         142
                                                                                                                                                                             ---                                      ---                                           ---                          ---
    Net after-tax exchange gains (losses)                                                                                                                                   $(31)                                     $11                                          $(75)                          $3
                                                                                                                                                                            ====                                      ===                                          ====                          ===

    As shown above, the "Total Exchange Gain (Loss)" is the sum of the "Subsidiary/Affiliate Monetary Position Gain (Loss)" and the "Hedging Program Gain (Loss)."

    Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
    Base income tax rate is defined as the effective income tax rate less the effect of exchange gains/losses, as defined above, and significant items.

                                                                                                                                                       Three Months Ended                           Six Months Ended
                                                                                                                                                            June 30,                                    June 30,
                                                                                                                                                            --------                                    --------
                                                                                                                                                                            2012                                     2011                                          2012                         2011
                                                                                                                                                                            ----                                     ----                                          ----                         ----

    Income before income taxes                                                                                                                                            $1,637                                   $1,589                                        $3,578                       $3,291
    Add:  Significant items - (benefit) charge (1)                                                                                                                           280                                      103                                           330                          103
    Less:  Net exchange gains (losses)                                                                                                                                        28                                        4                                           (52)                        (139)
                                                                                                                                                                             ---                                      ---                                           ---                         ----
    Income before income taxes, significant items and exchange gains/losses                                                                                               $1,889                                   $1,688                                        $3,960                       $3,533
                                                                                                                                                                          ======                                   ======                                        ======                       ======

    Provision for (benefit from) income taxes                                                                                                                               $449                                     $360                                          $890                         $618
    Add:  Tax benefits (expenses) on significant items                                                                                                                        65                                       22                                            83                           22
              Tax benefits (expenses) on exchange gains/losses                                                                                                               (59)                                       7                                           (23)                         142
                                                                                                                                                                             ---                                      ---                                           ---                          ---
    Provision for income taxes, excluding taxes on significant items                                                                                                        $455                                     $389                                          $950                         $782
       and exchange gains/losses
                                                                                                                                                                                                                                                                                                 ===

    Effective income tax rate                                                                                                                                               27.4%                                    22.7%                                         24.9%                        18.8%
    Significant items effect                                                                                                                                               (0.6%)                                   (0.1%)                                          0.0%                         0.1%
                                                                                                                                                                           -----                                    -----                                           ---                          ---
    Tax rate before significant items                                                                                                                                       26.8%                                    22.6%                                         24.9%                        18.9%
    Exchange gains (losses) effect                                                                                                                                         (2.7%)                                     0.4%                                        (0.9%)                         3.2%
                                                                                                                                                                           -----                                      ---                                         -----                          ---
    Base income tax rate                                                                                                                                                    24.1%                                    23.0%                                         24.0%                        22.1%
                                                                                                                                                                            ====                                     ====                                          ====                         ====

    (1)  See Schedule B for detail of significant items.

SOURCE DuPont


Source: PR Newswire